What are the treatment guidelines for self-harm in children and adolescents with potential underlying mental health issues, such as depression or anxiety, and impaired emotional regulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Guidelines for Self-Harm in Children and Adolescents

Dialectical Behavior Therapy for Adolescents (DBT-A) is the most evidence-based intervention for reducing self-harm in children and adolescents, demonstrating a significant reduction in repetition rates (30% vs 43% in controls) and should be offered where indicated. 1, 2

Comprehensive Assessment and Initial Management

Every adolescent presenting with self-harm must receive a comprehensive psychosocial assessment by a mental health professional, including:

  • Screening for suicidal ideation, specific plans, access to means, and intent 2
  • Formulation of contributing factors including interpersonal difficulties with family, romantic partners, and peers, negative attributional style, and symptoms of depression 1
  • Development of a detailed safety plan that must be regularly updated, incorporating identification of warning signs, specific coping strategies, social supports, means restriction, and emergency contacts 2
  • Immediate removal of all potentially lethal means from the home environment 2

First-Line Treatment: DBT-A

DBT-A demonstrates the strongest evidence for reducing both absolute repetition and frequency of self-harm (OR 0.46,95% CI 0.26 to 0.82) 1, 3. The treatment comprises:

  • Four essential modules that must all be delivered: Core Mindfulness Skills, Interpersonal Effectiveness Skills, Distress Tolerance, and Emotion Regulation Skills 2
  • Weekly individual therapy plus group skills training for the full 24-week protocol 2
  • Family involvement is mandatory to improve the home environment and model adaptive behaviors 2
  • Weekly group, family, and individual sessions, as well as telephone calls 1

Important Caveat About DBT-A

While DBT-A shows the most promise, it is unlikely to be realistic for most young people due to its time- and labor-intensive nature, requiring extensive training for therapists and a significant time commitment for families (generally 3-6 months) 1. Approximately half of young people offered therapy for self-harm do not attend all planned sessions, making engagement strategies critical 2, 4.

Alternative Psychotherapeutic Approaches

When DBT-A is unavailable or not feasible:

  • Cognitive Behavioral Therapy (CBT) adapted to the adolescent context may be of benefit for some young people 1, though current evidence shows no clear difference compared to treatment-as-usual (OR 0.93,95% CI 0.12 to 7.24) 1, 3
  • Specific psychological treatments (SPT) significantly improve treatment engagement compared to treatment-as-usual (28.4% non-completion vs 45.9% in TAU) 4
  • Family therapy shows no evidence of difference compared to treatment-as-usual or enhanced usual care on repetition of self-harm at post-intervention (OR 1.00,95% CI 0.49 to 2.07) 3

Critical Therapeutic Elements Across All Modalities

Regardless of the specific therapeutic approach chosen, the following components are essential:

  • Greater attention to the therapeutic relationship is an important consideration irrespective of the specific therapeutic modality 1
  • Family involvement wherever possible is a critical component of any therapeutic approach 1
  • Screen for suicidal ideation, self-harm urges, and safety at every session, with monitoring for repeat self-harm and reassessment of patient goals periodically 2

Pharmacotherapy Considerations

Pharmacotherapy is not recommended solely for the prevention of self-harm in young people 1. Key points include:

  • No evidence supports the use of medications specifically for self-harm prevention 1
  • Medications should only be prescribed for their indication for specific psychiatric disorders (e.g., antidepressants for concurrent depression) 1
  • SSRIs carry a black box warning for increased risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18-24) with major depressive disorder 5
  • If ADHD is present, continue stimulant treatment (e.g., lisdexamfetamine) as stimulants are first-line even in patients with self-harm and have lower lethal potential than alternatives 2

Staff Training and Service Delivery

Negative experiences of clinical services may perpetuate a cycle of self-harm, requiring attention to:

  • Staff training to ensure all clinical staff feel equipped to treat young people in a person-centred and compassionate manner 1
  • Easy access to immediate mentoring and supervision of emergency department staff who are involved with young people presenting after self-harm 1
  • Consideration of dedicating a separate area within the emergency department to triage and assess these presentations 1
  • Attitudes of professionals in clinical services may influence outcomes and are an important consideration in training 1

Common Pitfalls to Avoid

  • Do not rely on mentalisation-based therapy for adolescents (MBT-A) as evidence is very uncertain (OR 0.70,95% CI 0.06 to 8.46; very low-certainty evidence with substantial heterogeneity I² = 68%) 3
  • Do not prescribe medications solely for self-harm prevention, as there is no evidence supporting this approach and potential for harm with SSRIs 1, 5
  • Do not assume one single treatment approach will work for all young people, as self-harm results from a complex interplay of genetic, biological, psychological, psychiatric, social, and cultural factors 1
  • Do not underestimate engagement challenges, as approximately 50% of young people do not complete treatment, necessitating active engagement strategies and family involvement 2, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.